Search

Author/Creator Yamasaki, Sho

3. A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy. Issue 8 (August 2022)

Authors:
Sasaki, Kosaku; Murata, Masayuki; Nakamura, Keiji; Matsumoto, Yuji; Nakashima, Yuko; Yamasaki, Sho; Ota, Azusa; Hiramine, Satoshi; Takayama, Koji; Ikezaki, Hiroaki; Toyoda, Kazuhiro; Ogawa, Eiichi; Shimono, Nobuyuki
Journal:
Journal of infection and chemotherapy
Issue:
Volume 28:Issue 8(2022)
Page Start:
1208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Agonistic or antagonistic mucosal-associated invariant T (MAIT) cell activity is determined by the 6-alkylamino substituent on uracil MR1 ligands. Issue 39 (9th April 2020)

Authors:
Braganza, Chriselle D.; Motozono, Chihiro; Sonoda, Koh-Hei; Yamasaki, Sho; Shibata, Kensuke; Timmer, Mattie S. M.; Stocker, Bridget L.
Journal:
Chemical communications
Issue:
Volume 56:Issue 39(2020)
Page Start:
5291
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Characterisation of the murine C-type lectin receptor CLECSF8 (MCL) reveals its expression on cells of the monocyte/neutrophil lineages and an inter-dependence with Mincle, but not Dectin-2. Issue 1 (December 2015)

Authors:
Kerscher, Bernhard; Wilson, Gillian; Reid, Delyth; Yamasaki, Sho; Willment, Janet; Brown, Gordon
Journal:
Journal of inflammation
Issue:
Volume 12:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗